Follow on Google News News By Tag * Cancer * Diagnostic * Molecular * Drug * Diagnostics * Prostate * Genetic * Testing * Regulatory * Test * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | New Market Report: Advancing Molecular Diagnostics to Personalize Cancer TherapyNew Healthcare market report from Business Insights: "Advancing Molecular Diagnostics to Personalize Cancer Therapy"
Features and benefits * Identify key innovations in molecular diagnostics for oncology that may compete with those in development at your company. * Understand the regulatory challenges facing the developers of molecular diagnostics for cancer. * Understand the challenges that surround successfully commercializing a combined drug-diagnostic product and learn how to overcome them. * Discover and analyze the key technology platforms being used in the development of novel molecular diagnostics. * Discover the forecast market size for key segments of the cancer diagnostics market including: breast, colorectal, prostate, lung, and renal cancer. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Highlights Advances in genomics, proteomics, molecular imaging, and other new technologies are leading to a molecularly based reclassification of malignancy, creating market opportunities for diagnostic companies. Companion diagnostics - linking drugs with diagnostics - is expected to become the prevailing health care model, offering advantages for both the prescription drug and diagnostics businesses. For diagnostics companies, combining with a successful companion drug can be a powerful driver of sales, especially when required for prescribing a drug. If government regulatory agencies increase the use of biomarkers and diagnostics in prescribing decisions, it is likely that drug and diagnostics companies will increase their collaboration. New relationships are likely to develop between partners committed to personalized medicine embracing the approach of specialized pharmaceutical firms. Your key questions answered * Which of the cancer diagnostic market segments are forecast to grow most rapidly through to 2016 and thus be the most commercially attractive? * What are the key innovations in molecular diagnostics that are going to drive market growth? * How can pharma and diagnostic companies work together to successfully develop combined drug and diagnostic products? * Which companies are developing the most promising technologies? Partial Table of Contents: Executive Summary Introduction Trends in cancer diagnostics Market developments Market analysis About the author Disclaimer Introduction Summary Perspective Growing global incidence of cancer The impact of unhealthy lifestyles on cancer Personalized therapy gets closer Molecularly targeted therapeutics Move toward rationally designed trials Accelerate the translation of preclinical research Strategies toward personal cancer treatment Near-term market opportunities New pharmacogenomics, panels and arrays Driving demand for tests Drug-diagnostic co-development Targeted drugs fueling diagnostic growth Stratifying patients to the best treatment Trends in cancer diagnostics Summary An evolving science Demonstrating value Evolving health care practices Reducing time to market Addressing regulatory concerns Changing clinical practice Diagnostic influences therapeutic molecule discovery Identifying patient populations Key platforms PCR Nucleic acid testing Microfluidics Gene expression profiling Variety The role of biomarkers Prognostic Predictive Evaluating therapeutic activity Challenges and issues Commercializing theranostics Regulatory challenges Technical challenges DTCs and CTCs Market developments Summary New molecular test for cervical cancer Detecting high risk types of HPV License for EGFR lung cancer assay Licensing agreement extended for prostate cancer biomarker bioMerieux, GSK develop theranostic for treatment selection Diagnostic test for pancreatic cancer Test to select candidates for skin cancer immunotherapy Collaboration for therapy, companion diagnostic Companion diagnostics collaboration Deal to accelerate development of new cancer diagnosis tools Biomarkers for personalizing radiation cancer treatment CTC antibodies on a chip track mesothelioma Body fluid based oncology diagnostics Highly validated genetic markers for malignant melanoma Biomarkers for DNA methylation on melanoma tissue Diagnostic predicts prostate cancer recurrence Colorectal cancer test approved Market analysis Summary Market drivers Improving on prescription by trial and error A need for more rapid, specific testing Opportunities Drug-diagnostic combinations Rescuing failed drugs An unmet need for improving diagnosis Selected novel products on the market HPV and cervical cancer Multigene expression testing Predicting risk of recurrence Gene overexpression KRAS mutations Molecular classification Mutation analysis Drug resistance testing Measuring exposure to drugs World market analysis Total solutions Drug labeling modifications Breast cancer Colorectal cancer Prostate cancer Non-small cell lung cancer Melanoma Renal cancer Market by type of diagnostic Corporate Profiles Abbott Molecular Company description Agendia Company description Allegro Diagnostics Company description Almac Group Company description AltheaDx Company description Asuragen Company description Atossa Genetics Company description Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Insights Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and their aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors. By working in association with so many experts they are able to provide clients with more incisive market analysis specific to the client's industry sector. No other market analysis company provides such focused and trusted market analysis, across such a wide range of industry sectors. View more research from Business Insights at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number